Should you file a provisional patent for your drug invention? The honest answer.
Most founders in biotech don’t lose because they lack ideas. They lose because they move too slowly—or too vaguely—when it comes to protecting the science that makes their…

The patent cliff isn’t a cliff. It’s a countdown.
If you’re waiting until the last year of a drug’s exclusivity to think about supply, you’re already late.
In pharma, the “patent cliff” narrative is familiar: blockbuster revenues taper, generics and …

The 180-Day FDA Exclusivity Race Isn’t a Sprint—It’s a Strategy War. Here’s the Playbook.
If you’re in generics, biosimilars, or specialty pharma, you already know the headline: the first applicant to win the 180-day FDA exclusivity can capture outsize…

The PBM Endgame: What Mark Cuban Got Right—and Why Pharma Still Isn’t Listening
The pharmacy benefit manager (PBM) debate has been stuck in the same loop for years: everyone argues about “transparency,” everyone promises reform, and the system keeps qu…

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/

What long-term joint problems have been reported with Lipitor (atorvastatin)? Long-term joint side effects from Lipitor… https://www.Drugchatter.com/chat/47878/what-are-lipitor’s-long-term-joint-effects/